Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-24-041562)

Filing Details

Accession Number:: 0001140361-24-041562
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-09-20 16:05:24
Reporting Period:: 2024-09-18

Accepted Time:: 2024-09-20 16:05:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
887359	Vericel Corp	VCEL	Biological Products, (No Disgnostic Substances) (2836)	943096597

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1379970	C Steven Gilman	C/O Vericel Corporation 64 Sidney Street Cambridge MA 02139		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-09-18	5,834	$13.05	16,834	No	4	M	Direct
Common Stock	Disposition	2024-09-18	5,834	$45.54	11,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2024-09-18	5,834	$0.00	5,834	$13.05

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
11,666		2028-05-02	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024.
These options, representing the right to purchase 17,500 shares, became exercisable in equal monthly installments over a period of one year, beginning on May 2, 2018, contingent upon continued service to the Company.